1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Haemophilia A
1.2.3 Haemophilia B
1.3 Market by Application
1.3.1 Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 AmbulatorySurgicalCenters
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Perspective (2016-2027)
2.2 Hemophilia A and B Recombinant Factor Replacement Therapy Growth Trends by Regions
2.2.1 Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hemophilia A and B Recombinant Factor Replacement Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Hemophilia A and B Recombinant Factor Replacement Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Hemophilia A and B Recombinant Factor Replacement Therapy Industry Dynamic
2.3.1 Hemophilia A and B Recombinant Factor Replacement Therapy Market Trends
2.3.2 Hemophilia A and B Recombinant Factor Replacement Therapy Market Drivers
2.3.3 Hemophilia A and B Recombinant Factor Replacement Therapy Market Challenges
2.3.4 Hemophilia A and B Recombinant Factor Replacement Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hemophilia A and B Recombinant Factor Replacement Therapy Players by Revenue
3.1.1 Global Top Hemophilia A and B Recombinant Factor Replacement Therapy Players by Revenue (2016-2021)
3.1.2 Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hemophilia A and B Recombinant Factor Replacement Therapy Revenue
3.4 Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Concentration Ratio
3.4.1 Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hemophilia A and B Recombinant Factor Replacement Therapy Revenue in 2020
3.5 Hemophilia A and B Recombinant Factor Replacement Therapy Key Players Head office and Area Served
3.6 Key Players Hemophilia A and B Recombinant Factor Replacement Therapy Product Solution and Service
3.7 Date of Enter into Hemophilia A and B Recombinant Factor Replacement Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hemophilia A and B Recombinant Factor Replacement Therapy Breakdown Data by Type
4.1 Global Hemophilia A and B Recombinant Factor Replacement Therapy Historic Market Size by Type (2016-2021)
4.2 Global Hemophilia A and B Recombinant Factor Replacement Therapy Forecasted Market Size by Type (2022-2027)
5 Hemophilia A and B Recombinant Factor Replacement Therapy Breakdown Data by Application
5.1 Global Hemophilia A and B Recombinant Factor Replacement Therapy Historic Market Size by Application (2016-2021)
5.2 Global Hemophilia A and B Recombinant Factor Replacement Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size (2016-2027)
6.2 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type
6.2.1 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2021)
6.2.2 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2022-2027)
6.2.3 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2027)
6.3 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application
6.3.1 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2021)
6.3.2 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2022-2027)
6.3.3 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2027)
6.4 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country
6.4.1 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2016-2021)
6.4.2 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size (2016-2027)
7.2 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type
7.2.1 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2021)
7.2.2 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2022-2027)
7.2.3 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2027)
7.3 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application
7.3.1 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2021)
7.3.2 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2022-2027)
7.3.3 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2027)
7.4 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country
7.4.1 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2016-2021)
7.4.2 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size (2016-2027)
8.2 Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type
8.2.1 Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application
8.3.1 Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Region
8.4.1 Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size (2016-2027)
9.2 Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type
9.2.1 Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2027)
9.3 Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application
9.3.1 Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2027)
9.4 Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country
9.4.1 Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size (2016-2027)
10.2 Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type
10.2.1 Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application
10.3.1 Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country
10.4.1 Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
11.1.4 Pfizer Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Details
11.2.2 Novo Nordisk Business Overview
11.2.3 Novo Nordisk Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
11.2.4 Novo Nordisk Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021)
11.2.5 Novo Nordisk Recent Development
11.3 Baxalta
11.3.1 Baxalta Company Details
11.3.2 Baxalta Business Overview
11.3.3 Baxalta Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
11.3.4 Baxalta Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021)
11.3.5 Baxalta Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
11.4.4 Bayer Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021)
11.4.5 Bayer Recent Development
11.5 Biogen
11.5.1 Biogen Company Details
11.5.2 Biogen Business Overview
11.5.3 Biogen Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
11.5.4 Biogen Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021)
11.5.5 Biogen Recent Development
11.6 CSL Behring
11.6.1 CSL Behring Company Details
11.6.2 CSL Behring Business Overview
11.6.3 CSL Behring Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
11.6.4 CSL Behring Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021)
11.6.5 CSL Behring Recent Development
11.7 Emergent Biosolutions
11.7.1 Emergent Biosolutions Company Details
11.7.2 Emergent Biosolutions Business Overview
11.7.3 Emergent Biosolutions Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
11.7.4 Emergent Biosolutions Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021)
11.7.5 Emergent Biosolutions Recent Development
11.8 Spark therapeutics
11.8.1 Spark therapeutics Company Details
11.8.2 Spark therapeutics Business Overview
11.8.3 Spark therapeutics Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
11.8.4 Spark therapeutics Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021)
11.8.5 Spark therapeutics Recent Development
11.9 Uniqure
11.9.1 Uniqure Company Details
11.9.2 Uniqure Business Overview
11.9.3 Uniqure Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
11.9.4 Uniqure Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021)
11.9.5 Uniqure Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Haemophilia A
Table 3. Key Players of Haemophilia B
Table 4. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Regions (2016-2021)
Table 8. Global Hemophilia A and B Recombinant Factor Replacement Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Regions (2022-2027)
Table 10. Hemophilia A and B Recombinant Factor Replacement Therapy Market Trends
Table 11. Hemophilia A and B Recombinant Factor Replacement Therapy Market Drivers
Table 12. Hemophilia A and B Recombinant Factor Replacement Therapy Market Challenges
Table 13. Hemophilia A and B Recombinant Factor Replacement Therapy Market Restraints
Table 14. Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Players (2016-2021)
Table 16. Global Top Hemophilia A and B Recombinant Factor Replacement Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy as of 2020)
Table 17. Ranking of Global Top Hemophilia A and B Recombinant Factor Replacement Therapy Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Hemophilia A and B Recombinant Factor Replacement Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Hemophilia A and B Recombinant Factor Replacement Therapy Product Solution and Service
Table 21. Date of Enter into Hemophilia A and B Recombinant Factor Replacement Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue Market Share by Type (2016-2021)
Table 25. Global Hemophilia A and B Recombinant Factor Replacement Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue Market Share by Application (2016-2021)
Table 29. Global Hemophilia A and B Recombinant Factor Replacement Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Hemophilia A and B Recombinant Factor Replacement Therapy Product
Table 64. Pfizer Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Novo Nordisk Company Details
Table 67. Novo Nordisk Business Overview
Table 68. Novo Nordisk Hemophilia A and B Recombinant Factor Replacement Therapy Product
Table 69. Novo Nordisk Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021) & (US$ Million)
Table 70. Novo Nordisk Recent Development
Table 71. Baxalta Company Details
Table 72. Baxalta Business Overview
Table 73. Baxalta Hemophilia A and B Recombinant Factor Replacement Therapy Product
Table 74. Baxalta Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021) & (US$ Million)
Table 75. Baxalta Recent Development
Table 76. Bayer Company Details
Table 77. Bayer Business Overview
Table 78. Bayer Hemophilia A and B Recombinant Factor Replacement Therapy Product
Table 79. Bayer Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021) & (US$ Million)
Table 80. Bayer Recent Development
Table 81. Biogen Company Details
Table 82. Biogen Business Overview
Table 83. Biogen Hemophilia A and B Recombinant Factor Replacement Therapy Product
Table 84. Biogen Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021) & (US$ Million)
Table 85. Biogen Recent Development
Table 86. CSL Behring Company Details
Table 87. CSL Behring Business Overview
Table 88. CSL Behring Hemophilia A and B Recombinant Factor Replacement Therapy Product
Table 89. CSL Behring Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021) & (US$ Million)
Table 90. CSL Behring Recent Development
Table 91. Emergent Biosolutions Company Details
Table 92. Emergent Biosolutions Business Overview
Table 93. Emergent Biosolutions Hemophilia A and B Recombinant Factor Replacement Therapy Product
Table 94. Emergent Biosolutions Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021) & (US$ Million)
Table 95. Emergent Biosolutions Recent Development
Table 96. Spark therapeutics Company Details
Table 97. Spark therapeutics Business Overview
Table 98. Spark therapeutics Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021) & (US$ Million)
Table 99. Spark therapeutics Recent Development
Table 100. Uniqure Company Details
Table 101. Uniqure Business Overview
Table 102. Uniqure Hemophilia A and B Recombinant Factor Replacement Therapy Product
Table 103. Uniqure Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021) & (US$ Million)
Table 104. Uniqure Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Type: 2020 VS 2027
Figure 2. Haemophilia A Features
Figure 3. Haemophilia B Features
Figure 4. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. AmbulatorySurgicalCenters Case Studies
Figure 8. Hemophilia A and B Recombinant Factor Replacement Therapy Report Years Considered
Figure 9. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Regions: 2020 VS 2027
Figure 12. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Regions (2022-2027)
Figure 13. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Players in 2020
Figure 14. Global Top Hemophilia A and B Recombinant Factor Replacement Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Hemophilia A and B Recombinant Factor Replacement Therapy Revenue in 2020
Figure 16. Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue Market Share by Type (2016-2021)
Figure 17. Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue Market Share by Type (2022-2027)
Figure 18. North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Type (2016-2027)
Figure 20. North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Application (2016-2027)
Figure 21. North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Country (2016-2027)
Figure 22. United States Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Type (2016-2027)
Figure 26. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Application (2016-2027)
Figure 27. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Country (2016-2027)
Figure 28. Germany Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Region (2016-2027)
Figure 38. China Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Type (2016-2027)
Figure 46. Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Application (2016-2027)
Figure 47. Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Country (2016-2027)
Figure 48. Mexico Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Country (2016-2027)
Figure 54. Turkey Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Pfizer Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021)
Figure 58. Novo Nordisk Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021)
Figure 59. Baxalta Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021)
Figure 60. Bayer Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021)
Figure 61. Biogen Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021)
Figure 62. CSL Behring Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021)
Figure 63. Emergent Biosolutions Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021)
Figure 64. Spark therapeutics Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021)
Figure 65. Uniqure Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
【掲載企業】
Pfizer、Novo Nordisk、Baxalta、Bayer、Biogen、CSL Behring、Emergent Biosolutions、Spark therapeutics、Uniqure